3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase EARLY_PHASE1
1
Phase 1/2
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
3
NIH
1
Study Type
Interventional
3
Sponsor
Cancer Type
Other hematologic neoplasm
4
Thoracic
3
Plasma cell
3
Lymphoid
3
CNS
3
Myeloid
2
Dermatologic
2
Breast
2
Other
1
Gynecologic
1
Genitourinary
1
Classical hematology
1
Conditions
Multiple Myeloma
2121
Neoplasms, Plasma Cell
505
Lymphoma
354
Lymphoma, Non-Hodgkin
334
Hodgkin Disease
329
Leukemia, Lymphocytic, Chronic, B-Cell
307
Precursor Cell Lymphoblastic Leukemia-Lymphoma
299
Leukemia
290
Leukemia, Myeloid, Acute
270
Myelodysplastic Syndromes
263
Lymphoma, Mantle-Cell
228
Lymphoma, Follicular
224
Lymphoma, Large B-Cell, Diffuse
216
Lymphoma, B-Cell, Marginal Zone
206
Burkitt Lymphoma
201
Recurrence
188
Myeloproliferative Disorders
182
Lymphoma, Large-Cell, Immunoblastic
182
Immunoglobulin Light-chain Amyloidosis
162
Primary Myelofibrosis
153
Leukemia, Myeloid, Chronic-Phase
152
Leukemia, Myeloid, Accelerated Phase
143
Lymphoma, T-Cell, Cutaneous
140
Leukemia, Myelomonocytic, Chronic
133
Blast Crisis
131
Mycosis Fungoides
126
Sezary Syndrome
125
Congenital Abnormalities
122
Waldenstrom Macroglobulinemia
121
Leukemia, Hairy Cell
110
Interventions
fludarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Autoimmune Diseases
×
Plasma cell
×
Clear all
NCT01758042
2026-03-06
BMT
Massachusetts General Hospital
Phase NA
Completed
10 enrolled
NCT07032129
2025-06-22
BAH2573
Essen Biotech
Phase 1/2
Recruiting
60 enrolled
NCT04561557
2024-10-30
CARTinNS
Tongji Hospital
Phase EARLY_PHASE1
Recruiting
36 enrolled